Chemed Corporation (NYSE:CHE) reported Q2 EPS of $4.84, $0.06 better than the analyst estimate of $4.78. Revenue for the quarter came in at $531 million versus the consensus estimate of $538.07 million.
Chemed Corporation (NYSE:CHE) reported Q2 EPS of $4.84, $0.06 better than the analyst estimate of $4.78. Revenue for the quarter came in at $531 million versus the consensus estimate of $538.07 million.